VP, Investor Relations

Vir Biotechnology

Posted on: September 13, 2023

Closing: October 13, 2023

Salary: Undisclosed

Position Type: Full Time

Job Description

Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B and hepatitis D viruses, influenza A and human immunodeficiency virus.

We believe the success of our colleagues drives the success of our mission. We are committed to creating a company passionate about equality, inclusion, and respect. When everyone feels supported and encouraged to give their best, we will collectively deliver outstanding results. We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™.

The Vice President, Investor Relations, will build a strategic investor relations program to communicate our mission and progress to the investment community. Reporting to the EVP, Chief Corporate Affairs Officer, the Vice President, Investor Relations, will work with senior management, the Vice President of Corporate Communications, and multiple other leaders across the company. As the primary contact with the investment community, this is an important leadership role for Vir with responsibilities that span strategy and planning, content development and communication, and insights.


Strategy and Planning

  • Develop annual strategic investor relations program to communicate our strategies and progress to the investment community and adapt the program pending internal and external events.
  • Lead our participation in banking conferences, non-deal roadshows, R&D days, analyst days, bus tours, and 1-1 meetings.

Content Development and Communication

  • Develop an in-depth understanding of our technologies, programs, operations, financial performance, partners, competitors, and strategies.
  • Improve investor communications, including: corporate presentation decks, earnings releases, earnings and other conference call scripts, management Q&As, website content, the business section of Form 10-K.
  • Contribute to Board materials, other company press releases, and SEC documents (e.g., Form 8-Ks, Form S-3 fillings).
  • Create briefing materials for management in preparation for investor meetings.

Analysis and Insights

  • Be a primary contact for investment community, maintain database of interactions, and convey sentiments and feedback to management.
  • Analyze shareholder base and investment trends for our company, its peers, and its competitors to inform investor targeting strategy and monitor impact of strategy over time.
  • Follow sell-side models, including comparison to internal forecasts, to assess expectations and determine possible effects for analyst and investor communications.
  • Work with Competitive Intelligence function and other leaders across the company to understand competitor performance, and industry, regulatory, and other relevant trends, to inform unique corporate messaging.

Additional Responsibilities

  • Lead corporate ESG programs.
  • Collaborate on execution of the annual meeting of stockholders.
  • Partner with legal and corporate communications team to ensure all external communications are accurate, consistent. with corporate messaging, and compliant with securities regulations.


  • At least 10 years of investor relations experience in a publicly traded biotech/pharmaceutical company, at an investor relations firm working with biotech/pharmaceutical clients, or on the buy or sell-side working in biotech/pharmaceuticals.
  • BA/BS required, MBA, M.D., or relevant Ph.D. desired.
  • Outstanding written and oral communication skills.
  • Ability to present and respond to questions about complex scientific and clinical data.
  • Deep understanding of capital markets and the financial statements and valuation models used by investors and analysts.
  • Well versed in SEC and FDA regulations impacting investor and other external communications.
  • Highly collaborative working style across internal and external teams.


Vir’s compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes: compensation, bonus and equity as well as many other Vir benefits and perks such as: health, dental, vision, life and disability insurance benefits, non-accrual paid time off, company shut down for holidays, commuter benefits, child care reimbursement, education reimbursement, 401K match and lunch for all lab essential personnel!

Vir is an equal opportunity employer.  We value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, sex, gender, gender expression, sexual orientation, age, marital status, veteran status, or disability status. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform critical job functions, and to receive other benefits and privileges of employment. Please contact Human Resources to request accommodation.

Vir Biotechnology

Posted on: September 13, 2023

Closing: October 13, 2023

Salary($): Undisclosed

Position Type: Full Time

Similar Jobs

Rockford, United States

Lead, Quality Operations

Our investment is in People who make an impact, drive progress and creat...